
Aurobindo Pharma Limited has informed the Exchange regarding a press release dated Jun 23, 2023, titled "Eugia Pharma signs voluntary license with Medicines Patent Pool to develop and market generic version of Nilotinib Capsules.".
Filed with NSE ·

Aurobindo Pharma Limited has informed the Exchange regarding a press release dated Jun 23, 2023, titled "Eugia Pharma signs voluntary license with Medicines Patent Pool to develop and market generic version of Nilotinib Capsules.".
6ix hasn’t read this filing yet.
Follow Aurobindo Pharma into a list and get an email when it puts out news.
Follow Aurobindo Pharma